Chinese Journal of Dermatology ›› 2025, Vol. 58 ›› Issue (5): 464-469.doi: 10.35541/cjd.20230576
• Research Reports • Previous Articles Next Articles
Sun Yuxin, Huo Siyi, Chen Jiayu, Xiong Heping, Zhu Mingfang
Received:
2023-10-08
Revised:
2024-10-25
Online:
2025-05-15
Published:
2025-04-30
Contact:
Zhu Mingfang
E-mail:26715858@qq.com
Supported by:
Sun Yuxin, Huo Siyi, Chen Jiayu, Xiong Heping, Zhu Mingfang. COVID-19-associated skin diseases: a cross-sectional survey in Changsha, China[J]. Chinese Journal of Dermatology, 2025, 58(5): 464-469.doi:10.35541/cjd.20230576
[1] | Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China[J]. N Engl J Med, 2020,382(18):1708⁃1720. doi: 10.1056/NEJMoa2002032. |
[2] | Recalcati S. Cutaneous manifestations in COVID⁃19: a first perspective[J]. J Eur Acad Dermatol Venereol, 2020,34(5):e212⁃e213. doi: 10.1111/jdv.16387. |
[3] | Freeman EE, McMahon DE, Lipoff JB, et al. The spectrum of COVID⁃19⁃associated dermatologic manifestations: an international registry of 716 patients from 31 countries[J]. J Am Acad Dermatol, 2020,83(4):1118⁃1129. doi: 10.1016/j.jaad. 2020.06.1016. |
[4] | 杜娟, 林岚梅, 徐金华, 等. 新阶段因新冠感染诱发的皮肤损害及对策[J]. 中国皮肤性病学杂志, 2023,37(2):123⁃127. doi: 10.13735/j.cjdv.1001⁃7089.202212094. |
[5] | Mohseni Afshar Z, Babazadeh A, Hasanpour A, et al. Dermatological manifestations associated with COVID⁃19: a comprehensive review of the current knowledge[J]. J Med Virol, 2021,93(10):5756⁃5767. doi: 10.1002/jmv.27187. |
[6] | Shimizu H, Matsumoto H, Sasajima T, et al. New⁃onset dermatomyositis following COVID⁃19: a case report[J]. Front Immunol, 2022,13:1002329. doi: 10.3389/fimmu.2022.1002329. |
[7] | Sharquie KE, Jabbar RI. COVID⁃19 infection is a major cause of acute telogen effluvium[J]. Ir J Med Sci, 2022,191(4):1677⁃1681. doi: 10.1007/s11845⁃021⁃02754⁃5. |
[8] | Kocatürk E, Muñoz M, Elieh⁃Ali⁃Komi D, et al. How infection and vaccination are linked to acute and chronic urticaria: a special focus on COVID⁃19[J]. Viruses, 2023,15(7):1585. doi: 10.3390/v15071585. |
[9] | 邓维, 张高磊, 陈见友, 等. 61例儿童新型冠状病毒感染的皮肤表现分析[J]. 中华皮肤科杂志, 2023,56(12):1154⁃1157. doi: 10.35541/cjd.20220910. |
[10] | Oztas Kara R, Sevimli Dikicier B. Clinical features and outcomes of acute versus chronic urticaria triggered by COVID⁃19 infection[J]. Adv Skin Wound Care, 2024,37(4):1⁃5. doi: 10.1097/ASW.0000000000000118. |
[11] | Mobasheri L, Nasirpour MH, Masoumi E, et al. SARS⁃CoV⁃2 triggering autoimmune diseases[J]. Cytokine, 2022,154:155873. doi: 10.1016/j.cyto.2022.155873. |
[12] | Kocatürk E, Salman A, Cherrez⁃Ojeda I, et al. The global impact of the COVID⁃19 pandemic on the management and course of chronic urticaria[J]. Allergy, 2021,76(3):816⁃830. doi: 10.1111/all.14687. |
[13] | Cosansu NC, Yuksekal G, Kutlu O, et al. The change in the frequency and severity of facial dermatoses and complaints in healthcare workers during the COVID⁃19[J]. J Cosmet Dermatol, 2022,21(8):3200⁃3205. doi: 10.1111/jocd.15044. |
[14] | Singh GK, Mitra B, Bhatnagar A, et al. Unusual spurts of rosacea like dermatoses, posing a diagnostic dilemma during Covid⁃19 pandemic: a cross⁃sectional, observational study from a tertiary care centre[J]. Indian J Dermatol, 2021,66(4):401⁃404. doi: 10.4103/ijd.IJD_759_20. |
[15] | Nguyen B, Tosti A. Alopecia areata after COVID⁃19 infection and vaccination: a cross⁃sectional analysis[J]. J Eur Acad Dermatol Venereol, 2023,37(1):e7⁃e8. doi: 10.1111/jdv.18491. |
[16] | Kim J, Hong K, Gómez Gómez RE, et al. Lack of evidence of COVID⁃19 being a risk factor of alopecia areata: results of a national cohort study in South Korea[J]. Front Med (Lausanne), 2021,8:758069. doi: 10.3389/fmed.2021.758069. |
[17] | Rajabi F, Drake LA, Senna MM, et al. Alopecia areata: a review of disease pathogenesis[J]. Br J Dermatol, 2018,179(5):1033⁃1048. doi: 10.1111/bjd.16808. |
[18] | Ghafoor R, Ali SM, Patil A, et al. Association of androgenetic alopecia and severity of coronavirus disease 2019[J]. J Cosmet Dermatol, 2022,21(3):874⁃879. doi: 10.1111/jocd.14683. |
[19] | Wambier CG, Goren A, Vaño⁃Galván S, et al. Androgen sensitivity gateway to COVID⁃19 disease severity[J]. Drug Dev Res, 2020,81(7):771⁃776. doi: 10.1002/ddr.21688. |
[20] | Otsuka Y, Nakano Y, Hagiya H, et al. Recovery from alopecia after COVID⁃19[J]. Cureus, 2022,14(1):e21160. doi: 10.7759/cureus.21160. |
[21] | Elgardt I, Carmi O, Levy Y. IgA nephropathy (Henoch⁃Schönlein purpura) associated with recent COVID⁃19 infection[J]. Isr Med Assoc J, 2022,24(11):697⁃698. |
[22] | Magro C, Mulvey JJ, Berlin D, et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID⁃19 infection: a report of five cases[J]. Transl Res, 2020,220:1⁃13. doi: 10.1016/j.trsl.2020.04.007. |
[23] | Chularojanamontri L, Tuchinda P, Rujitharanawong C, et al. New⁃onset and exacerbated skin diseases after COVID⁃19 infection: a systematic review[J]. J Dermatol, 2022,49(11):e419⁃e421. doi: 10.1111/1346⁃8138.16501. |
[24] | 陈瑞, 梁文, 蒋雨薇, 等. 新型冠状病毒肺炎疫情期间医护人员皮肤损伤流行病学调查及特征分析[J]. 中华皮肤科杂志, 2020,53(11):923⁃927. doi: 10.35541/cjd.20200356. |
[25] | 李珊珊, 梁宇, 潘志婷, 等. "后疫情时期"新冠肺炎患者创伤后应激障碍现状及影响因素分析[J]. 中国医院管理, 2021,41(8):79⁃82. |
[26] | 杨敬铭, 王鑫, 刘丽改, 等. 感染新型冠状病毒患者的焦虑特质与心理健康的相关性研究[J]. 首都医科大学学报, 2023,44(4):609⁃613. doi: 10.3969/j.issn.1006⁃7795.2023.04.017. |
[27] | Kyrou I, Karteris E, Robbins T, et al. Polycystic ovary syndrome (PCOS) and COVID⁃19: an overlooked female patient population at potentially higher risk during the COVID⁃19 pandemic[J]. BMC Med, 2020,18(1):220. doi: 10.1186/s12916⁃020⁃01697⁃5. |
[28] | Seyed Resuli A, Bezgal M. Subacute thyroiditis in COVID⁃19 patients[J]. Ear Nose Throat J, 2022,101(8):501⁃505. doi: 10.1177/01455613211012114. |
[29] | Xu Y, Gao R, Zhu G, et al. Genetic variation of allergic disease is associated with the susceptibility to COVID⁃19[J]. J Infect, 2022,84(5):e92⁃e93. doi: 10.1016/j.jinf.2022.01.015. |
[30] | Chhapola Shukla S. ACE2 expression in allergic airway disease may decrease the risk and severity of COVID⁃19[J]. Eur Arch Otorhinolaryngol, 2021,278(7):2637⁃2640. doi: 10.1007/s00405⁃020⁃06408⁃7. |
[31] | 窦进法, 王建波, 张帅, 等. 新型冠状病毒感染疫情期间接受生物制剂治疗的中重度斑块状银屑病患者病情变化及影响因素分析: 单中心横断面研究[J]. 中华皮肤科杂志, 2024,57(8):739⁃742. doi: 10.35541/cjd.20230167. |
[32] | Cazzato G, Cascardi E, Colagrande A, et al. SARS⁃CoV⁃2 and skin: new insights and perspectives[J]. Biomolecules, 2022,12(9):1212. doi: 10.3390/biom12091212. |
[33] | Barda N, Dagan N, Ben⁃Shlomo Y, et al. Safety of the BNT162b2 mRNA Covid⁃19 vaccine in a nationwide setting[J]. N Engl J Med, 2021,385(12):1078⁃1090. doi: 10.1056/NEJMoa2110475. |
[34] | Sun Q, Fathy R, McMahon DE, et al. COVID⁃19 vaccines and the skin: the landscape of cutaneous vaccine reactions worldwide[J]. Dermatol Clin, 2021,39(4):653⁃673. doi: 10.1016/j.det. 2021.05.016. |
[35] | El⁃Qushayri AE, Nardone B. Psoriasis exacerbation after COVID⁃19 vaccines: a brief report of the reported cases[J]. Dermatol Ther, 2022,35(12):e15900. doi: 10.1111/dth.15900. |
[1] | He Chunxia, Jin Hongzhong . Principles, current status, challenges and perspectives in the diagnosis and treatment of critical dermatological emergencies [J]. Chinese Journal of Dermatology, 2025, 58(4): 307-314. |
[2] | Dong Yi, Yan Xin, Munire·Tayier, Zhang Xingqi. Application of machine learning in dermatology [J]. Chinese Journal of Dermatology, 2025, 0(3): 20240290-e20240290. |
[3] | Li Yuancheng, Han Renqiang, Miao Weigang, Luo Pengfei. Incidence trends and age distribution of cutaneous melanoma in Jiangsu province from 2010 to 2019 [J]. Chinese Journal of Dermatology, 2025, 58(3): 228-233. |
[4] | Chinese Association of Rehabilitation Dermatology, Chinese Society of Dermatology, Photomedicine Therapeutic Equipment Group, Committee on Skin Disease and Cosmetic Dermatology, China Association of Medical Equipment. Clinical application of red, blue, and yellow light therapy in dermatology: an expert consensus statement (2025 edition) [J]. Chinese Journal of Dermatology, 2025, 58(3): 209-215. |
[5] | Committee on Skin Disease and Cosmetic Dermatology, China Association of Medical Equipment. Expert consensus on the treatment of dermatoses with targeted drugs (2025 version) [J]. Chinese Journal of Dermatology, 2025, 58(2): 99-125. |
[6] | Ai Fangting, Sun Zijun, Miao Guoying, Yao Chunxia. Role of calcium-sensing receptors in the pathophysiology of skin of the elderly [J]. Chinese Journal of Dermatology, 2025, 58(1): 76-79. |
[7] | Zhang Jiaqi, Wu Fan, Han Yuqing, Liu Qi, Pan Yao. Application of multi-photon microscopy in dermatology [J]. Chinese Journal of Dermatology, 2024, 57(9): 857-862. |
[8] | Hao Feng, Liu Guoyan. Application of optical coherence tomography in dermatology [J]. Chinese Journal of Dermatology, 2024, 57(9): 853-857. |
[9] | Zou Xianbiao, Chen Jinchun, Zeng Yue, Hao Yi. Application of ultrasonography in dermatology: progress and prospects [J]. Chinese Journal of Dermatology, 2024, 57(9): 785-790. |
[10] | Zeng Yue, Shao Huihong, Lin Shiwen, Wen Rou, Zou Xianbiao. Application of a wearable teleconsultation device in diagnosis of common skin diseases [J]. Chinese Journal of Dermatology, 2024, 57(9): 797-800. |
[11] | Luo Li, Zhang Bona, Wu Wei, Tang Wenjing, Li Yuehua, Liu Xiaoli, Ma Yanan, Li Cuicui, Qi Mengyan, Sun Ni, Shi Qiong. Efficacy and safety of 308-nm excimer laser and 308-nm excimer lamp in the treatment of 194 children with vitiligo: a retrospective study [J]. Chinese Journal of Dermatology, 2024, 57(8): 721-727. |
[12] | Zhang Shuo, Zhang Wei, Xu Dan. Associations of telogen effluvium with coronavirus disease 2019 and research progress in its diagnosis and treatment [J]. Chinese Journal of Dermatology, 2024, 57(8): 761-764. |
[13] | Wang Chen, Xue Chenhong, Song Jinghui, Li Jianguo, Li Zhenlu, Zhang Shoumin, Li Ming, Wang Jianbo. Adalimumab for the treatment of three cases of Blau syndrome in a pedigree [J]. Chinese Journal of Dermatology, 2024, 57(6): 553-556. |
[14] | Jing Ke, Li Suo, Feng Suying. Clinical and immunoserological characteristics of 26 cases of linear IgA bullous dermatosis: a retrospective analysis [J]. Chinese Journal of Dermatology, 2024, 57(6): 503-509. |
[15] | Han Yan, Xu Peng, Xiang Zhi, Jiang Tingting, Ge Fengqin, Yin Yueping, Chen Xiangsheng, . Strengthening research on prevention and treatment of chronic skin diseases — population medicine research program [J]. Chinese Journal of Dermatology, 2024, 57(6): 567-569. |
|